The CReATe Consortium and American Brain Foundation Young Investigator Award funds early-career clinical research on ALS and related neurodegenerative diseases, in collaboration with the American Academy of Neurology.
Funder: American Academy of Neurology
Due Dates (Anticipated): March 2027 (Full application deadline, projected)
Funding Amounts: Typically supports 1 early-career investigator; award size and duration vary by cycle and are announced with each call.
Summary: Supports young investigators conducting clinical research on ALS, ALS-FTD, PLS, PMA, and HSP in collaboration with the American Academy of Neurology.
Key Information: 2027 cycle will not be administered by the American Academy of Neurology; check the program page for updates.
This award, funded by the CReATe Consortium and the American Brain Foundation, aims to foster the next generation of clinical researchers focused on neurodegenerative diseases, specifically amyotrophic lateral sclerosis (ALS), ALS-frontotemporal dementia (ALS-FTD), primary lateral sclerosis (PLS), progressive muscular atrophy (PMA), and hereditary spastic paraplegia (HSP). The program is designed for early-career investigators and is presented in collaboration with the American Academy of Neurology. The award enables recipients to advance innovative clinical research in these challenging areas of neurology.